Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kelly Edwards Irwin, M.D.

Co-Author

This page shows the publications co-authored by Kelly Irwin and Elyse Park.
Connection Strength

2.331
  1. Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia. Psychiatr Serv. 2019 10 01; 70(10):927-934.
    View in: PubMed
    Score: 0.857
  2. Feasibility and Acceptability of a Collaborative Lung Cancer Screening Educational Intervention Tailored for Individuals With Serious Mental Illness. J Am Coll Radiol. 2021 Aug 07.
    View in: PubMed
    Score: 0.247
  3. Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial. JAMA. 2020 10 13; 324(14):1406-1418.
    View in: PubMed
    Score: 0.233
  4. Expanding Access to Cancer Clinical Trials for Patients With Mental Illness. J Clin Oncol. 2019 06 20; 37(18):1524-1528.
    View in: PubMed
    Score: 0.210
  5. Improving Lung Cancer Screening Access for Individuals With Serious Mental Illness. J Am Coll Radiol. 2019 Apr; 16(4 Pt B):596-600.
    View in: PubMed
    Score: 0.210
  6. Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer. Oncologist. 2019 07; 24(7):901-910.
    View in: PubMed
    Score: 0.207
  7. Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia. Oncologist. 2017 11; 22(11):1374-1382.
    View in: PubMed
    Score: 0.184
  8. Increasing Lung Screening in the Latino Community. J Am Coll Radiol. 2021 05; 18(5):633-636.
    View in: PubMed
    Score: 0.061
  9. Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE. J Pain Symptom Manage. 2017 01; 53(1):131-138.
    View in: PubMed
    Score: 0.044
  10. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract. 2015 May; 11(3):e405-12.
    View in: PubMed
    Score: 0.040
  11. Processes of discontinuing chemotherapy for metastatic non-small cell lung cancer at the end of life. J Clin Oncol. 2014 Nov; 32(31_suppl):96.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.